C21 Investments Announces Q2 Earnings Date and Provides Operational Update
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has announced its expected date for reporting Q2 financial results for the period ended September 30, 2024. The company will release these results on November 15, 2024. C21 provided an operational update, highlighting strong sales growth from its new South Reno dispensary, which opened at the end of Q1. The new location's sales grew from $273,000 in July to $417,000 in September.
Overall sales for Q2 (July-September) were $7.5 million, a 14% increase from Q1 sales of $6.6 million. CEO Sonny Newman expressed excitement about the growth generated by the new dispensary and its positive customer reception, evidenced by a 4.9 Google review score. The company aims to continue scaling operations and improving margins, positioning itself for further growth in Nevada.
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ha annunciato la data prevista per la pubblicazione dei risultati finanziari del secondo trimestre per il periodo conclusosi il 30 settembre 2024. L'azienda prevede di divulgare questi risultati il 15 novembre 2024. C21 ha fornito un aggiornamento operativo, evidenziando una forte crescita delle vendite dal nuovo dispensario di South Reno, aperto alla fine del primo trimestre. Le vendite della nuova sede sono aumentate da $273.000 a luglio a $417.000 a settembre.
Le vendite complessive per il secondo trimestre (luglio-settembre) sono state di $7,5 milioni, con un aumento del 14% rispetto alle vendite del primo trimestre di $6,6 milioni. Il CEO Sonny Newman ha espresso entusiasmo per la crescita generata dal nuovo dispensario e dalla sua positiva accoglienza da parte dei clienti, come dimostrato da un punteggio di 4,9 su Google. L'azienda mira a continuare a scalare le operazioni e a migliorare i margini, posizionandosi per una ulteriore crescita in Nevada.
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ha anunciado su fecha esperada para la publicación de los resultados financieros del segundo trimestre para el periodo que finaliza el 30 de septiembre de 2024. La compañía dará a conocer estos resultados el 15 de noviembre de 2024. C21 proporcionó una actualización operativa, destacando un fuerte crecimiento en las ventas de su nuevo dispensario en South Reno, que abrió a finales del primer trimestre. Las ventas del nuevo local crecieron de $273,000 en julio a $417,000 en septiembre.
Las ventas totales para el segundo trimestre (julio-septiembre) fueron de $7.5 millones, un aumento del 14% en comparación con las ventas del primer trimestre de $6.6 millones. El CEO Sonny Newman expresó su entusiasmo por el crecimiento generado por el nuevo dispensario y su positiva recepción por parte de los clientes, evidenciada por un puntaje de 4.9 en Google. La empresa tiene como objetivo seguir escalando sus operaciones y mejorar los márgenes, posicionándose para un mayor crecimiento en Nevada.
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF)는 2024년 9월 30일 기준 제2분기 재무 결과 발표 예정일을 발표했습니다. 회사는 이 결과를 2024년 11월 15일에 공개할 예정입니다. C21은 새로운 사우스 레노 매장에서의 강력한 매출 성장에 대한 운영 업데이트를 제공했습니다. 새로운 매장의 매출은 7월 27만 3천 달러에서 9월 41만 7천 달러로 증가했습니다.
제2분기(7월-9월) 총 매출은 750만 달러로, 1분기 매출 660만 달러 대비 14% 증가했습니다. CEO 소니 뉴먼은 새로운 매장에서 발생한 성장과 긍정적인 고객 반응에 대해 흥분을 표명했으며, 이는 구글 리뷰 점수 4.9로 입증되었습니다. 회사는 운영을 계속 확장하고 마진을 개선하여 네바다에서 추가 성장을 위한 입지를 다질 계획입니다.
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) a annoncé sa date prévue pour la publication des résultats financiers du deuxième trimestre pour la période se terminant le 30 septembre 2024. La société publiera ces résultats le 15 novembre 2024. C21 a fourni une mise à jour opérationnelle, soulignant une forte croissance des ventes de son nouveau dispensaire de South Reno, qui a ouvert à la fin du premier trimestre. Les ventes de ce nouvel emplacement ont augmenté de 273 000 $ en juillet à 417 000 $ en septembre.
Les ventes globales pour le deuxième trimestre (juillet-septembre) ont atteint 7,5 millions $, soit une augmentation de 14% par rapport aux ventes du premier trimestre de 6,6 millions $. Le PDG Sonny Newman a exprimé son enthousiasme concernant la croissance générée par le nouveau dispensaire et la réponse positive des clients, comme en témoigne un score de 4,9 sur Google. L'entreprise vise à continuer à étendre ses opérations et à améliorer ses marges, se positionnant pour une croissance supplémentaire au Nevada.
C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) hat das erwartete Datum für die Veröffentlichung der finanziellen Ergebnisse des zweiten Quartals für den Zeitraum, der am 30. September 2024 endet, bekannt gegeben. Das Unternehmen wird diese Ergebnisse am 15. November 2024 veröffentlichen. C21 gab ein operatives Update und hob das starke Umsatzwachstum seines neuen Dispensar in South Reno hervor, das Ende des ersten Quartals eröffnet wurde. Die Umsätze des neuen Standorts stiegen von 273.000 USD im Juli auf 417.000 USD im September.
Insgesamt beliefen sich die Umsätze im zweiten Quartal (Juli-September) auf 7,5 Millionen USD, was einem 14% Anstieg gegenüber den Umsätzen im ersten Quartal von 6,6 Millionen USD entspricht. CEO Sonny Newman äußerte sich begeistert über das Wachstum, das durch das neue Dispensar generiert wurde, sowie über die positive Kundenresonanz, die durch einen Google-Bewertungspunkt von 4,9 belegt ist. Das Unternehmen strebt an, die Betriebe weiter auszubauen und die Margen zu verbessern, um sich für weiteres Wachstum in Nevada zu positionieren.
- New South Reno dispensary shows strong sales growth, increasing from $273,000 in July to $417,000 in September
- Overall Q2 sales increased by 14% quarter-over-quarter, reaching $7.5 million
- High customer satisfaction for the new dispensary, with a 4.9 Google review score
- None.
New Dispensary Generating Strong Sales Growth during the Quarter
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its second quarter financial results for the period ended September 30, 2024. The Company is also taking the opportunity to provide an operational update for the period. All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period to a March 31st year-end and will not have traditional year-over-year comparable reporting periods during this current fiscal year.
The Company is pleased to share an update on its existing operations for the upcoming second quarter, ended September 30, 2024. C21 anticipates releasing these results on November 15, 2024. This quarter will be the first to include results from its newest Silver State Relief dispensary located in South Reno, which opened at the end of Q1 (see news release dated June 10, 2024). This is C21's third dispensary in Nevada. The South Reno dispensary generated strong sales growth in its first three months of operations with sales of
CEO and President, Sonny Newman stated, "We are excited to report our second quarter results in November which will include the growth generated from our newest dispensary. Perhaps most gratifying is the customer reception to the new store, as signified by our 4.9 Google review score. We will continue to focus on scaling our operations, with an emphasis on continuing to drive margin improvement. The Company is well-positioned to pursue additional opportunities to further grow its Nevada footprint and market share."
For further inquiries, please contact:
Investor contact:
Investor Relations
info@cxxi.ca
+1 833 289-2994
Company contact:
Michael Kidd
Chief Financial Officer and Director
Michael.Kidd@cxxi.ca
About C21 Investments Inc.
C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, additional information on C21 can be found at www.sedarplus.ca and www.cxxi.ca.
Cautionary Note Regarding Forward-Looking Information and Statements:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, "Forward-Looking Statements"). Forward-Looking Statements in this news release include but are not limited to the Company's focus on ramping its new store and continuing to pursue additional opportunities in the market; and improving margins. Such Forward-Looking Statements represent the Company's beliefs and expectations regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.
Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: achieving the anticipated results of the Company's strategic plans; and general economic, financial market, regulatory and political conditions in which the Company operates.
A variety of factors, including known and unknown risks, many of which are beyond the Company's control, could cause actual results to differ materially from the Forward-Looking Statements in this news release. Such factors include, without limitation: risks and uncertainties arising from: the inability to effectively manage growth; inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; the adequacy of the Company's capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute the Company's business plan (either within the expected timeframe or at all); changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana; the risks of operating in the marijuana industry in the United States, and those other risk factors discussed in the Company's 20F filing with the U.S. Securities and Exchange Commission and Annual Information Form filing on SEDAR+.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the Forward-Looking Statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such Forward-Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Should assumptions underlying the Forward-Looking Statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The Forward-Looking Statements contained in this news release are made as of the date of this news release, and the Company does not undertake to update any Forward-Looking Statements that are contained or referenced herein, except in accordance with applicable securities laws.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227242
FAQ
When will C21 Investments (CXXIF) release its Q2 2024 financial results?
How much did C21 Investments' (CXXIF) new South Reno dispensary generate in sales for September 2024?
What was C21 Investments' (CXXIF) total sales for Q2 2024, and how does it compare to Q1?
How many dispensaries does C21 Investments (CXXIF) now operate in Nevada?
